Search research articles
Contact Us
Filters
Showing results (131-140 of 343) with videos related to
Page
of 35
Sort By:
International Journal of Cancer
|
February 2, 2006
Regular aspirin use and esophageal cancer risk
Vijayvel Jayaprakash, Ravi J Menezes, Milind M Javle, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
April 17, 2007
CD24 expression is an independent prognostic marker in cholangiocarcinoma
Shefali Agrawal, Boris W Kuvshinoff, Thaer Khoury, et al.
Gastrointestinal Cancer Research : GCR
|
February 2, 2012
Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis
Karen R Eckmann, Dina K Patel, Andrea Landgraf, et al.
Cancer
|
November 10, 2004
Risk factors associated with earlier age of onset in familial pancreatic carcinoma
Ted A James, David G Sheldon, Ashwani Rajput, et al.
Pancreas
|
December 6, 2012
Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: a tertiary cancer center experience
Muslim Atiq, Manoop S Bhutani, William A Ross, et al.
Biorxiv : the Preprint Server for Biology
|
April 20, 2026
A Counterfactual Framework for Directional Cell-Cell Interaction Analysis in Spatial Transcriptomics
Humaira Anzum, Veena Kochat, Suresh Satpati, et al.
Journal of Gastrointestinal Oncology
|
November 12, 2025
Ethnic and socioeconomic disparities in survival outcomes among patients under 65 years with intrahepatic cholangiocarcinoma: a SEER analysis
Adit Dharia, Lianchun Xiao, Janak Abraham, et al.
Journal of Translational Medicine
|
November 8, 2018
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Morten Lapin, Satu Oltedal, Kjersti Tjensvoll, et al.
JAMA Oncology
|
March 4, 2021
Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants: Findings From 2 Phase 2 Nonrandomized Clinical Trials
Milind Javle, Einat Shacham-Shmueli, Lianchun Xiao, et al.
Anticancer Research
|
October 23, 2009
High-dose octreotide acetate for management of gastroenteropancreatic neuroendocrine tumors
Manpreet K Chadha, Jeffrey Lombardo, Terry Mashtare, et al.
Page
of 35
Search research articles
Search
Showing results (131-140 of 343) with videos related to
Sort By:
Page
of 35
International Journal of Cancer
|
February 2, 2006
Regular aspirin use and esophageal cancer risk
Vijayvel Jayaprakash, Ravi J Menezes, Milind M Javle, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
April 17, 2007
CD24 expression is an independent prognostic marker in cholangiocarcinoma
Shefali Agrawal, Boris W Kuvshinoff, Thaer Khoury, et al.
Gastrointestinal Cancer Research : GCR
|
February 2, 2012
Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis
Karen R Eckmann, Dina K Patel, Andrea Landgraf, et al.
Cancer
|
November 10, 2004
Risk factors associated with earlier age of onset in familial pancreatic carcinoma
Ted A James, David G Sheldon, Ashwani Rajput, et al.
Pancreas
|
December 6, 2012
Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: a tertiary cancer center experience
Muslim Atiq, Manoop S Bhutani, William A Ross, et al.
Biorxiv : the Preprint Server for Biology
|
April 20, 2026
A Counterfactual Framework for Directional Cell-Cell Interaction Analysis in Spatial Transcriptomics
Humaira Anzum, Veena Kochat, Suresh Satpati, et al.
Journal of Gastrointestinal Oncology
|
November 12, 2025
Ethnic and socioeconomic disparities in survival outcomes among patients under 65 years with intrahepatic cholangiocarcinoma: a SEER analysis
Adit Dharia, Lianchun Xiao, Janak Abraham, et al.
Journal of Translational Medicine
|
November 8, 2018
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Morten Lapin, Satu Oltedal, Kjersti Tjensvoll, et al.
JAMA Oncology
|
March 4, 2021
Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants: Findings From 2 Phase 2 Nonrandomized Clinical Trials
Milind Javle, Einat Shacham-Shmueli, Lianchun Xiao, et al.
Anticancer Research
|
October 23, 2009
High-dose octreotide acetate for management of gastroenteropancreatic neuroendocrine tumors
Manpreet K Chadha, Jeffrey Lombardo, Terry Mashtare, et al.
Page
of 35